Ye Y, Si Z H, Moore J P, Sodroski J
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 10016, USA.
J Virol. 2000 Dec;74(24):11955-62. doi: 10.1128/jvi.74.24.11955-11962.2000.
The in vivo passage of a neutralization-sensitive, laboratory-adapted simian-human immunodeficiency virus (SHIV-HXBc2) generated a pathogenic, neutralization-resistant virus, SHIV-HXBc2P 3.2. SHIV-HXBc2P 3.2 differs from SHIV-HXBc2 only in 13 amino acid residues of the viral envelope glycoproteins. Here we used antibody competition analysis to examine the structural changes that occurred in the SHIV-HXBc2P 3.2 gp120 exterior envelope glycoprotein. The relationships among the antibody epitopes on the conserved gp120 core of SHIV-HXBc2 and SHIV-HXBc2P 3.2 were similar. The third variable (V3) loop was more closely associated with the fourth conserved (C4) region and CD4-induced epitopes on the gp120 core in the HXBc2P 3.2 gp120 glycoprotein compared with the HXBc2 gp120 glycoprotein. Rearrangements of the second variable (V2) loop with respect to the CD4 binding site and associated epitopes were evident in comparisons of the two gp120 glycoproteins. Thus, the in vivo evolution of a neutralization-resistant virus involves conformational adjustments of the V2 and V3 variable loops with respect to the conserved receptor-binding regions of the gp120 core.
一种对中和敏感的、实验室适应的猿猴 - 人类免疫缺陷病毒(SHIV - HXBc2)在体内传代后产生了一种致病性的、对中和有抗性的病毒SHIV - HXBc2P 3.2。SHIV - HXBc2P 3.2与SHIV - HXBc2的区别仅在于病毒包膜糖蛋白的13个氨基酸残基。在此,我们使用抗体竞争分析来检测SHIV - HXBc2P 3.2的gp120外膜包膜糖蛋白中发生的结构变化。SHIV - HXBc2和SHIV - HXBc2P 3.2保守的gp120核心上抗体表位之间的关系相似。与HXBc2 gp120糖蛋白相比,在HXBc2P 3.2 gp120糖蛋白中,第三个可变(V3)环与gp120核心上的第四个保守(C4)区域和CD4诱导的表位联系更为紧密。在比较两种gp120糖蛋白时,第二个可变(V2)环相对于CD4结合位点和相关表位的重排很明显。因此,一种对中和有抗性的病毒在体内的进化涉及V2和V3可变环相对于gp120核心保守的受体结合区域的构象调整。